Effect of ascorbate on fibrinolytic factors in septic mouse skeletal muscle

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 7, 2014, Pages 745-753

  Swarbreck, Scott ^a,b   Secor, Dan ^a,b   Li, Fuyan ^a,b   Gross, Peter L ^c   Ellis, Christopher G ^a,b   Sharpe, Michael D ^b   Wilson, John X ^d   Tyml, Karel ^a,b  

^a Victoria Research Laboratories   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Ascorbate; Capillary; Fibrinolysis; Platelets; Sepsis; Thrombelastography

Indexed keywords

ANTIPLASMIN; ASCORBIC ACID; FIBRINOLYTIC FACTOR; HEART MUSCLE EXTRACT; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; STREPTOKINASE; UROKINASE; PROTEASE NEXIN I; SERPINE2 PROTEIN, MOUSE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY FLOW; CONTROLLED STUDY; EX VIVO STUDY; FIBRINOLYSIS; GENE EXPRESSION; HYPOCOAGULABILITY; LIVER HOMOGENATE; MALE; MOUSE; MUSCLE CAPILLARY; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SKELETAL MUSCLE; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; ZYMOGRAPHY; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; VASCULARIZATION;

ANIMALS; ASCORBIC ACID; FIBRINOLYSIS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; RNA, MESSENGER; SEPSIS; SERPIN E2; THROMBELASTOGRAPHY; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84927696899     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000138     Document Type: Article

References (33)

1. Vincent JL. Clinical sepsis and septic shock-definition, diagnosis and management principles. Langenbecks Arch Surg 2008; 393:817-824; doi: 10.1007/s00423-008-0343-1.
2. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831.
3. Tyml K, Li F, Wilson JX. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med 2008; 36:2355-2362.
4. Secor D, Li F, Ellis CG, Sharpe MD, Gross PL, Wilson JX, et al. Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med 2010; 36:1928-1934; doi: 10.1007/s00134-010-1969-3.
5. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592; doi: 10.1056/NEJM199908193410807.
6. Helling H, Schenk HJ, Pindur G, Weinrich M, Wagner B, Stephan B. Fibrinolytic and procoagulant activity in septic and haemorrhagic shock. Clin Hemorheol Microcirc 2010; 45:295-300; doi: 10.3233/CH-2010- 1309.
7. Takada A, Takada Y. The physiology of the fibrinolytic system. Jpn J Physiol 1993; 43:1-19.
8. Chatterjee M, Saluja R, Kumar V, Jyoti A, Kumar Jain G, Kumar Barthwal M, et al. Ascorbate sustains neutrophil NOS expression, catalysis, and oxidative burst. Free Radic Biol Med 2008; 45:1084-1093; doi: 10.1016/j.freeradbiomed.2008.06.028.
9. Zimmerman GA. Hypoxic erythrocytes spark lung leukocyte adhesion. Blood 2008; 111:4831-4832; doi: 10.1182/blood-2008-02-140947.
10. Oszajca K, Bieniasz M, Brown G, Swiatkowska M, Bartkowiak J, Szemraj J. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol 2008; 86:477-486; doi: 10.1139/ o08-137.
11. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109:144-148.
12. Raeven P, Feichtinger GA, Weixelbaumer KM, Atzenhofer S, Redl H, Van Griensven M, et al. Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis. Thromb Res 2012; 129:e238-e245; doi: 10.1016/j.thromres.2012.02.004; 10.1016/j.thromres.2012.02.004.
13. Choi NS, Kim BY, Lee JY, Yoon KS, Han KY, Kim SH. Relationship between acrylamide concentration and enzymatic activity in an improved single fibrin zymogram gel system. J Biochem Mol Biol 2002; 35:236-238.
14. Brogren H, Wallmark K, Deinum J, Karlsson L, Jern S. Platelets retain high levels of active plasminogen activator inhibitor 1. PLoS One 2011; 6:e26762; doi: 10.1371/journal.pone.0026762; 10.1371/journal.pone.0026762.
15. Secor D, Swarbreck S, Ellis CG, Sharpe MD, Tyml K. Ascorbate reduces mouse platelet aggregation and surface P-selectin expression in an ex vivo model of sepsis. Microcirculation 2013; 20:502-510; doi: 10.1111/ micc.12047; 10.1111/micc.12047.
16. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90; doi: 10.1111/j.1365-2257.2005.00681.x.
17. Serrano R, Barrenetxe J, Orbe J, Rodriguez JA, Gallardo N, Martinez C, et al. Tissue-specific PAI-1 gene expression and glycosylation pattern in insulinresistant old rats. Am J Physiol Regul Integr Comp Physiol 2009; 297:R1563-R1569; doi: 10.1152/ajpregu.00093.2009.
18. Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxintreated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996; 97:2440-2451; doi: 10.1172/JCI118691.
19. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar JR, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest 2007; 131:1735-1741; doi: 10.1378/chest.06-2233.
20. Marshall JC. Sepsis: rethinking the approach to clinical research. J Leukoc Biol 2008; 83:471-482; doi: 10.1189/jlb.0607380.
21. Ganopolsky JG, Castellino FJ. A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 2004; 165:1433-1446; doi: 10.1016/S0002-9440(10)63401-3.
22. Miyaji T, Hu X, Yuen PS, Muramatsu Y, Iyer S, Hewitt SM, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 2003; 64:1620-1631; doi: 10.1046/j.1523-1755.2003.00268.x.
23. Quax PH, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990; 265:15560-15563.
24. Robbie LA, Dummer S, Booth NA, Adey GD, Bennett B. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br J Haematol 2000; 109:342-348.
25. Ngo TH, Verheyen S, Knockaert I, Declerck PJ. Monoclonal antibodybased immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples. Thromb Haemost 1998; 79:808-812.
26. Nylander M, Osman A, Ramstrom S, Aklint E, Larsson A, Lindahl TL. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets. Thromb Res 2012; 129:e51-e58; doi: 10.1016/j.thromres.2011.12.021.
27. Jiang Q, Gingles NA, Olivier MA, Miles LA, Parmer RJ. The antifibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. Blood 2011; 117:7155-7163; doi: 10.1182/blood-2010-05-287672; 10.1182/blood-2010-05- 287672.
28. Idell S. Endothelium and disordered fibrin turnover in the injured lung: Newly recognized pathways. Crit Care Med 2002; 30 (5 Suppl):S274-S280.
29. van der Poll T, Levi M, Buller HR, van Deventer SJ, de Boer JP, Hack CE, et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174:729-732.
30. van der Poll T, Jansen PM, Montegut WJ, Braxton CC, Calvano SE, Stackpole SA, et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 1997; 158:1971-1975.
31. Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009; 20:419-426; doi: 10.1097/ MBC.0b013e32832a76e1.
32. Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Wegelin JA, Brophy D, et al. Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol 2012; 303:L20-32; doi: 10.1152/ajplung.00300.2011.
33. Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem 2012; 56:67-83.